Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gridlock from Diagnosis to Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania: Illuminating Potential Factors for Possible Intervention.
Liyoyo AA, Heysell SK, Kisonga RM, Lyimo JJ, Mleoh LJ, Mutayoba BK, Lekule IA, Mmbaga BT, Kibiki GS, Mpagama SG. Liyoyo AA, et al. Among authors: mleoh lj. East Afr Health Res J. 2017;1(1):31-39. doi: 10.24248/EAHRJ-D-16-00330. Epub 2017 Mar 1. East Afr Health Res J. 2017. PMID: 34308156 Free PMC article.
Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study.
Semvua HH, Mtabho CM, Fillekes Q, van den Boogaard J, Kisonga RM, Mleoh L, Ndaro A, Kisanga ER, van der Ven A, Aarnoutse RE, Kibiki GS, Boeree MJ, Burger DM. Semvua HH, et al. Antivir Ther. 2013;18(1):105-13. doi: 10.3851/IMP2413. Epub 2012 Oct 5. Antivir Ther. 2013. PMID: 23043067 Clinical Trial.
Implementation of the 'Removed Injectable modified Short-course regimens for EXpert Multidrug Resistant Tuberculosis' (RISE study) in Tanzania: a protocol for a mixed-methods process evaluation.
Kalolo A, Lalashowi J, Pamba D, Shayo PJ, Gitige C, Mvungi H, Ntagazwa W, Lekule I, Kisonga R, Mleoh L, John J, Kapologwe NA, Mutayoba B, Matechi E, Mpagama SG, Ntinginya NE. Kalolo A, et al. BMJ Open. 2022 May 24;12(5):e054434. doi: 10.1136/bmjopen-2021-054434. BMJ Open. 2022. PMID: 35613774 Free PMC article.
Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol.
Jerene D, Levy J, van Kalmthout K, Rest JV, McQuaid CF, Quaife M, Charalambous S, Gamazina K, Garfin AMC, Mleoh L, Terleieva Y, Bogdanov A, Maraba N, Fielding K. Jerene D, et al. BMJ Open. 2023 Mar 14;13(3):e068685. doi: 10.1136/bmjopen-2022-068685. BMJ Open. 2023. PMID: 36918242 Free PMC article.